About Us

Archives






Spectral Announces Second Quarter Results and Provides Corporate Update

Posted: August 15, 2021 at 1:51 am


TORONTO, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock, as well as commercializing a new proprietary platform targeting the renal replacement therapy market through its wholly-owned subsidiary Dialco Medical Inc. (Dialco), today announced its financial results for the second quarter ended June 30, 2021, and provided a corporate update.

Read the original:
Spectral Announces Second Quarter Results and Provides Corporate Update

Related Post

No Comments

No comments yet.

Sorry, the comment form is closed at this time.